Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: Result of a randomized multicenter trial (BETACAR Trial)
- 10 November 2006
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 113 (2), 153-160
- https://doi.org/10.1016/j.ijcard.2005.06.067
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialThe Lancet, 2003
- Should ACE inhibition always be first-line therapy in heart failure? Lessons from the CARMEN Study.Cardiovascular Drugs and Therapy, 2003
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II TrialCirculation, 2001
- Differential Effects of β-Blockers in Patients With Heart FailureCirculation, 2000
- Beta-blockade in heart failure: A comparison of carvedilol with metoprololJournal of the American College of Cardiology, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Prognostic Value of Bisoprolol-Induced Hemodynamic Effects in Heart Failure During the Cardiac Insufficiency BIsoprolol Study (CIBIS)Circulation, 1997